Angélica C. Kottkamp, MD, FIDSA
849 posts

Angélica C. Kottkamp, MD, FIDSA
@angelickott
Infectologist @ NYU | HIV Doctor | ❤️ Virology - HIV - Vaccines - Medical Education - Global Health | She/Her/Ella | Views are mine - Proud 🇨🇴 COL














At IDWeek 2024 in LA, NYU Vaccine Center Associate Director, Dr Angelica Cifuentes Kottkamp, shared latest results from mpox vaccine study during her Best Abstract Presentation in the Smadel Lecture Plenary session. @NYUGSOM_ID @IDCRC_LG @HelpEndHIV



Blown away by the brilliance of my colleague @angelickott who gave the IDSA Featured Oral Abstract Joseph Smadell Lecture today @IDWeekmtg on humoral responses to mpox. A huge accomplishment! So impressed with you and the entire team @NYUGSOM_ID Vaccine Center!!! #IDTwitter


"Remember this product is for who? This is not a Gucci handbag for rich people. This is a product for people who live on the margins.” - @UNAIDS Executive Director @Winnie_Byanyima 🇺🇳 at #AIDS2024 media roundtable on long-acting injectables, #PutPeopleFirst

En las opciones del Co-chair en #AIDS2024 inicia con el nuevo paciente Berlin. Un hombre nacido en 1964 que adquiere VIH en 2009. Inicia TAR en 2015 y se diagnostica LMA. Trasp autologo fr células madre hem heterocigoto a mut delta32 CCR5 + 1/


